lcp
We have detected you are using Internet Explorer. To provide the best and most secure experience, please use a modern browser as we do not support Internet Explorer.

Medcast news and blog

Gout in Focus: Why is it important and how do we achieve better outcomes?

Join Dr Kate Annear as she discusses Gout with Professor Ric Day, a highly experienced rheumatologist and clinical pharmacologist. This podcast will cover why gout is important, and will also address some of the common misconceptions surrounding this condition as well as providing some practical advice on supporting better outcomes in the management of this condition.

READ ON
Managing gout in 2024 – are you up to date?
Managing gout in 2024 – are you up to date?
Dr Kate Annear

Gout, a chronic inflammatory condition, is often undertreated despite its impact on quality of life. Misconceptions include it being only a lifestyle disease or affecting only older men. Effective management requires lifelong urate-lowering therapy and addressing both pharmacologic and non-pharmacologic factors.

Challenges of diagnosis and management of eczema in patients with skin of colour
Challenges of diagnosis and management of eczema in patients with skin of colour
Quality Use of Medicines Alliance

This clinical update offers guidance on diagnosis and management of eczema in individuals with skin of colour, including adapting assessments, considering differential diagnoses, addressing pigmentation changes, and aligning treatment with cultural practices for effective care.

Optimising paediatric Eczema Care: A Nurses’ Guide
Optimising paediatric Eczema Care: A Nurses’ Guide
Susan Helmrich

Explore essential strategies and insights for managing paediatric eczema effectively in this guide. From daily skincare routines to addressing common triggers and mental health considerations, empower families with the knowledge and tools to improve their child's quality of life.

My patients are concerned about the safety of topical corticosteroids – should they be?
My patients are concerned about the safety of topical corticosteroids – should they be?
Dr Kate Annear

Stories about topical steroid withdrawal are difficult to put into context for both consumers and health professionals. The outcome is that many consumers are avoiding using topical corticosteroids, which in many cases, makes it harder to manage conditions such as eczema.

Navigating the Eczema Journey
Navigating the Eczema Journey
Dr Kate Annear

Jaime has suffered from severe eczema for most of his life. This podcast delves into the interactions that take place between consumers and health professionals in the eczema journey. 

Medcast makes a new home for quality use of medicines education
Medcast makes a new home for quality use of medicines education
Quality Use of Medicines Alliance

QHUB, launched by Medcast, is a new home for quality use of medicine education. Supported by the Australian Government, it offers healthcare professionals and consumers free, comprehensive resources on key health issues, starting with eczema.

Facial eczema in an infant - Clinical Opal
Facial eczema in an infant - Clinical Opal
Quality Use of Medicines Alliance

Some parents and health professionals are hesitant to use topical corticosteroid on sensitive skin regions such as the face. Moreover, in young children there can be a tendency by parents (often influenced by friends/family/social media) to assume food as a cause of eczema, which may give rise to unnecessary restrictions of diet.

Beyond Skin Deep: Unravelling the challenges of managing eczema
Beyond Skin Deep: Unravelling the challenges of managing eczema
Dr Kate Annear

Dr Artiene Tatian and Ms Melanie Funk discuss the impact and burden of eczema on individuals and families and address some of the management challenges for health professionals.

Why eczema, why now?
Why eczema, why now?
Quality Use of Medicines Alliance

Every day around 2.8 million Australians, many of them young children, are directly impacted by the itch, inflammation and discomfort of eczema. Countless more are indirectly affected.